medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2013, Number 2

<< Back Next >>

Rev Mex Patol Clin Med Lab 2013; 60 (2)

Frequency of hypertriglyceridemias in mexican population outpatien

Olay FG, Hernández MA

Language: Spanish
References: 15
Page: 110-115
PDF size: 51.32 Kb.


ABSTRACT

The objective of this study was to determine the distribution and frequency of hypertriglyceridemias in an open population in Mexico City. 161,270 samples were conducted on outpatients to whom their Triglycerides serum levels were measured. The results obtained were classified by sex and age groups according to NOM-037-SSA2-2002-37 criteria for dyslipidemias prevention, treatment, and control. The results show that the female group presented a 19.5% concentration is borderline, 19.8% of this group associated with high risk and 0.15% with very high risk for cardiovascular illnesses. The group of male 20.5% is borderline, 25.8% for high risk and 0.51% at very high risk, according to the NOM-037-SSA2-2002-37. The majority of them were between 41 and 60 years old of both sex groups.


REFERENCES

  1. Instituto Nacional de Salud. Implicaciones de salud en la obesidad. 5(9) Enero 2011.

  2. Aguilar SCA. Diagnóstico y tratamiento de las dislipidemias: posición de la Sociedad Mexicana de Nutrición y Endocrinología. Rev Endocrinol Nutr 2004; 12 (1): 7-41.

  3. Miguel Soca Pedro Enrique. Dislipidemias. ACIMED 2009; 20 (6): 265-273.

  4. NORMA Oficial Mexicana NOM-037-SSA2-2002, Para la prevención, tratamiento y control de las dislipidemias.

  5. Martínez HA, Chávez AR. Prevalencia y comorbilidad de dislipidemias en el primer nivel de atención, Rev Med Inst Mex Seg Soc 2007; 45 (5): 469-475.

  6. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998; 81: 7B-12B.

  7. Trejo-Gutiérrez J. Ateroesclerosis. En: Vargas-Barrón J. Tratado de cardiología. México: Intersistemas; 2006. p. 130-154.

  8. Aguilar-Salinas CA, Olaiz G, Valles V, Ríos JM, Gómez PFJ, Rull JA et al. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J Lipid Research 2001; 42: 1298-1307.

  9. Durrington P. Dyslipidemia. Lancet 2003; 362: 717-731.

  10. Cueto-García L. Prevención de la aterosclerosis en México. México: Intersistemas; 1989. p. 185-197.

  11. Vulkov I. Percentile reference values of lipid risk factors of ischemic heart disease: Cholesterol, LDL-cholesterol, LDLcholesterol and triglycerides in individuals aged 20 to 60 years in Plovdiv region. Folia Med (Plovdiv) 1997; 39: 37-45.

  12. Williams CM. Cardiovascular risk factors in women. Proc Nutr Soc 1997; 56: 383-391.

  13. Simkin-Silverman LR, Wing RR. Weight gain during menopause. Is it inevitable or can be prevented? Postgrad Med 2000; 108: 47-56.

  14. Lasses y Ojeda LA, Torres Gutiérrez JA, Salazar E. Dislipidemia en el anciano. Arch Cardiol Mex 2004; 74 (4): 315-26.

  15. Majmudar NG, Robson SC, Ford GA. Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. J Clin Endocrinol Metabol 2000; 85: 1577-1583.




2020     |     www.medigraphic.com